3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Pancreatic Neoplasms
4
Uterine Cervical Neoplasms
3
Squamous Cell Carcinoma of Head and Neck
3
Carcinoma, Squamous Cell
3
Rectal Neoplasms
2
Head and Neck Neoplasms
2
Carcinoma, Non-Small-Cell Lung
2
Carcinoma
2
Adenocarcinoma Of Esophagus
2
Tonsillar Neoplasms
1
Resectable Esophageal Cancer
1
Pharyngeal Neoplasms
1
Neoplasms by Site
1
Neoplasms
1
Muscle Invasive Bladder Cancer
1
Melanoma
1
Lung Neoplasms
1
Limited Stage Small Cell Lung Cancer
1
Glioblastoma
1
Esophageal Squamous Cell Carcinoma
1
Esophageal Neoplasms
1
Colorectal Neoplasms
1
Carcinoma, Adenosquamous
1
Brain Neoplasms
1
Adenocarcinoma
1
Interventions
Gemcitabine
6
Irinotecan
4
130-nm albumin-bound paclitaxel
4
Cisplatin
3
Albumin-Bound Paclitaxel
3
napabucasin
2
Leucovorin
2
Imatinib Mesylate
2
Everolimus
2
Ascorbic Acid
2
spartalizumab
1
pralsetinib
1
pembrolizumab
1
dostarlimab
1
copanlisib
1
alectinib
1
Ramucirumab
1
Paclitaxel
1
NUC-1031
1
Levoleucovorin
1
KRN-330
1
HhAntag691
1
Fluorouracil
1
Cyclophosphamide
1
Capecitabine
1
Bevacizumab
1
5,10-methylenetetrahydrofolic acid
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has results
×
Digestive System Neoplasms
×
Chemoradiotherapy
×
Clear all
No trials found.